US-based pharmaceutical firm Merck has received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for its investigational oral combination regimen MK-5172/MK-8742 for the treatment of chronic hepatitis C virus ...
Pharmaceutical firm Merck reported a net income of $906m, or $0.30 per share for the second quarter ended on 30 June 2013 compared to $1.8bn, or $0.58 per share in 2012. Total revenue for the second quarter ended on 30 June 2013 was ...
Tags: Merck, Pharmaceutical firm
Pharmaceutical firm Merck has reported a 4% decline in its net sales in the third quarter 2012 to $11.5bn, as against $12.02bn for the same quarter in 2011. The firm's GAAP net income for the third quarter declined to $1.79bn, down from ...
Tags: Pharmaceutical firm Merck, Merck's pharmaceutical sales